A rectal cancer organoid platform to study individual responses to chemoradiation
Rectal cancer (RC) is a challenging disease to treat that requires chemotherapy, radiation
and surgery to optimize outcomes for individual patients. No accurate model of RC exists to …
and surgery to optimize outcomes for individual patients. No accurate model of RC exists to …
Colorectal cancer develops inherent radiosensitivity that can be predicted using patient-derived organoids
…, C Wu, S Bodo, S Klingler, CEG Sauvé, BC Szeglin… - Cancer research, 2022 - AACR
Abstract Analysis of inherent tissue radiosensitivity of patient-derived organoids may
provide a readout predictive of neoadjuvant therapy response to radiation in rectal cancer, …
provide a readout predictive of neoadjuvant therapy response to radiation in rectal cancer, …
[HTML][HTML] A claudin-based molecular signature identifies high-risk, chemoresistant colorectal cancer patients
Identifying molecular characteristics that are associated with aggressive cancer phenotypes
through gene expression profiling can help predict treatment responses and clinical …
through gene expression profiling can help predict treatment responses and clinical …
Evaluating the Validity of the Clavien–Dindo Classification in Colectomy Studies: A 90-Day Cost of Care Analysis
…, PD Strombom, RL Gennarelli, BC Szeglin… - Diseases of the Colon …, 2021 - journals.lww.com
BACKGROUND: The Clavien–Dindo classification is widely used to report postoperative
morbidity but may underestimate the severity of colectomy complications. OBJECTIVE: The …
morbidity but may underestimate the severity of colectomy complications. OBJECTIVE: The …
A SMAD4‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer
BC Szeglin, C Wu, MR Marco, HS Park… - Cancer …, 2022 - Wiley Online Library
Background Colorectal cancer is the second‐leading cause of cancer‐related mortality in the
United States and a leading cause of cancer‐related mortality worldwide. Loss of SMAD4, …
United States and a leading cause of cancer‐related mortality worldwide. Loss of SMAD4, …
Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion
Background Resection of colorectal liver metastases (CLM) can cure disease, but many
patients with extensive disease cannot be fully resected and others recur following surgery. …
patients with extensive disease cannot be fully resected and others recur following surgery. …
A rectal cancer model establishes a platform to study individual responses to chemoradiation
Rectal cancer (RC) is a challenging disease to treat that requires chemotherapy, radiation,
and surgery to optimize outcomes for individual patients. No accurate model of RC exists to …
and surgery to optimize outcomes for individual patients. No accurate model of RC exists to …
Mismatch repair–deficient rectal cancer and resistance to neoadjuvant chemotherapy
… C, Tumoroid ex vivo sensitivity to FOLFOX demonstrating relative sensitivity to FOLFOX in
pMMR tumoroids and resistance in dMMR tumoroids with calculated IC50 values reported as …
pMMR tumoroids and resistance in dMMR tumoroids with calculated IC50 values reported as …
SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance
Purpose: SMAD4 has shown promise in identifying patients with colorectal cancer at high
risk of recurrence or death. Experimental Design: A discovery cohort and independent …
risk of recurrence or death. Experimental Design: A discovery cohort and independent …
Test–retest reliability of freesurfer measurements within and between sites: Effects of visual approval process
In the last decade, many studies have used automated processes to analyze magnetic
resonance imaging (MRI) data such as cortical thickness, which is one indicator of neuronal …
resonance imaging (MRI) data such as cortical thickness, which is one indicator of neuronal …